The Retinal Pigment Epithelium: Something More than a Constituent of the Blood-Retinal Barrier—Implications for the Pathogenesis of Diabetic Retinopathy

The retinal pigment epithelium (RPE) is an specialized epithelium lying in the interface between the neural retina and the choriocapillaris where it forms the outer blood-retinal barrier (BRB). The main functions of the RPE are the following: (1) transport of nutrients, ions, and water, (2) absorption of light and protection against photooxidation, (3) reisomerization of all-trans-retinal into 11-cis-retinal, which is crucial for the visual cycle, (4) phagocytosis of shed photoreceptor membranes, and (5) secretion of essential factors for the structural integrity of the retina. An overview of these functions will be given. Most of the research on the physiopathology of diabetic retinopathy has been focused on the impairment of the neuroretina and the breakdown of the inner BRB. By contrast, the effects of diabetes on the RPE and in particular on its secretory activity have received less attention. In this regard, new therapeutic strategies addressed to modulating RPE impairment are warranted.

[1]  R. Simó,et al.  Vitreous levels of erythropoietin in patients with macular oedema secondary to retinal vein occlusions: a comparative study with diabetic macular oedema , 2009, Eye.

[2]  H. Yamashita,et al.  Neuroprotective effects of erythropoietin on glutamate and nitric oxide toxicity in primary cultured retinal ganglion cells , 2005, Brain Research.

[3]  M F Marmor,et al.  Control of subretinal fluid: Experimental and clinical studies , 1990, Eye.

[4]  K. Hayes,et al.  Retinal pigment epithelium possesses both LDL and scavenger receptor activity. , 1989, Investigative ophthalmology & visual science.

[5]  R. Simó,et al.  Interphotoreceptor retinoid-binding protein (IRBP) is downregulated at early stages of diabetic retinopathy , 2009, Diabetologia.

[6]  H. Tanihara,et al.  Elevated erythropoietin in vitreous with ischemic retinal diseases , 2004, Neuroreport.

[7]  G. Chader,et al.  Interphotoreceptor retinoid-binding protein (IRBP) , 1993, Molecular Neurobiology.

[8]  R. H. Steinberg,et al.  Localization of frog retinal pigment epithelium Na+-K+ ATPase. , 1980, Experimental eye research.

[9]  Sheldon S. Miller,et al.  Passive ionic properties of frog retinal pigment epithelium , 1977, The Journal of Membrane Biology.

[10]  F. Gonzalez-fernandez,et al.  Interphotoreceptor retinoid-binding protein––an old gene for new eyes , 2003, Vision Research.

[11]  M. Weller,et al.  Similar protective effects of BQ-123 and erythropoietin on survival of neural cells and generation of neurons upon hypoxic injury. , 2005, European journal of cell biology.

[12]  J. Robertson,et al.  Cultured human retinal pigment epithelial cells express basic fibroblast growth factor and its receptor. , 1989, Current eye research.

[13]  P. Bagnoli,et al.  Physiology and pathology of somatostatin in the mammalian retina: A current view , 2008, Molecular and Cellular Endocrinology.

[14]  F. Giordano,et al.  Use of the ARPE-19 cell line as a model of RPE polarity: basolateral secretion of FGF5. , 1998, Investigative ophthalmology & visual science.

[15]  T. Kitaoka,et al.  Increasing cell density down-regulates the expression of acidic FGF by human RPE cells in vitro. , 1993, Current eye research.

[16]  D. Bok,et al.  Phagocytosis of outer segments by retinal pigment epithelium: phagosome-lysosome interaction. , 1993, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[17]  W. Blaner,et al.  Early Onset Photoreceptor Abnormalities Induced by Targeted Disruption of the Interphotoreceptor Retinoid-Binding Protein Gene , 1998, The Journal of Neuroscience.

[18]  D. Bok,et al.  Aquaporin-1 channels in human retinal pigment epithelium: role in transepithelial water movement. , 2003, Investigative ophthalmology & visual science.

[19]  R. Kuijpers,et al.  Somatostatin receptor 2A expression in choroidal neovascularization secondary to age-related macular degeneration. , 2000, Investigative ophthalmology & visual science.

[20]  R. Kuijpers,et al.  Somatostatin and somatostatin receptors in retinal diseases. , 2000, European journal of endocrinology.

[21]  O. Rorstad,et al.  Immunoreactive and biologically active somatostatin-like material in the human retina , 1980, Brain Research.

[22]  S. Juul,et al.  Tissue distribution of erythropoietin and erythropoietin receptor in the developing human fetus. , 1998, Early human development.

[23]  A. Verkman,et al.  Functions of aquaporins in the eye , 2008, Progress in Retinal and Eye Research.

[24]  Z. Werb,et al.  Matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-1 in the retinal pigment epithelium and interphotoreceptor matrix: vectorial secretion and regulation. , 1997, Experimental eye research.

[25]  S. Sagar,et al.  Somatostatin-like immunoreactive material in associational ganglion cells of human retina , 1988, Neuroscience.

[26]  A. Kijlstra,et al.  Retinal Pigment Epithelium-immune System Interactions: Cytokine Production and Cytokine-induced Changes , 2001, Progress in Retinal and Eye Research.

[27]  J. Folkman,et al.  Synthesis and secretion of vascular permeability factor/vascular endothelial growth factor by human retinal pigment epithelial cells. , 1993, Biochemical and biophysical research communications.

[28]  L. Rizzolo,et al.  Differential regulation of tight junction permeability during development of the retinal pigment epithelium. , 2000, American journal of physiology. Cell physiology.

[29]  S. H. Wilson,et al.  Modulation of retinal endothelial cell behaviour by insulin-like growth factor I and somatostatin analogues: implications for diabetic retinopathy. , 2001, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

[30]  M. Boulton,et al.  The role of oxidative stress in the pathogenesis of age-related macular degeneration. , 2000, Survey of ophthalmology.

[31]  M. Inatani,et al.  Growth factors and their receptors in the retina and pigment epithelium , 1997, Progress in Retinal and Eye Research.

[32]  R. Simó,et al.  Elevation of apolipoprotein A-I and apolipoprotein H levels in the vitreous fluid and overexpression in the retina of diabetic patients. , 2008, Archives of ophthalmology.

[33]  Wei Dai,et al.  Intravitreal injection of erythropoietin protects both retinal vascular and neuronal cells in early diabetes. , 2008, Investigative ophthalmology & visual science.

[34]  R. Simó,et al.  Vitreous levels of erythropoietin in patients with macular oedema secondary to retinal vein occlusions: a comparative study with diabetic macular oedema , 2009, Eye.

[35]  G. Chader,et al.  Interphotoreceptor retinoid-binding protein: role in delivery of retinol to the pigment epithelium. , 1989, Experimental eye research.

[36]  L. Montuenga,et al.  Pigment epithelium-derived factor in the monkey retinal pigment epithelium and interphotoreceptor matrix: apical secretion and distribution. , 2004, Experimental eye research.

[37]  J. Kane,et al.  High density lipoprotein mediated lipid efflux from retinal pigment epithelial cells in culture , 2006, British Journal of Ophthalmology.

[38]  J. Bennett,et al.  Pigment epithelium-derived factor expression in the developing mouse eye. , 2002, Molecular vision.

[39]  J. Kane,et al.  Human retinal pigment epithelial cells express scavenger receptors BI and BII. , 2002, Biochemical and biophysical research communications.

[40]  Lawrence A Leiter,et al.  Apolipoprotein A-I Q[-2]X causing isolated apolipoprotein A-I deficiency in a family with analphalipoproteinemia. , 1994, The Journal of clinical investigation.

[41]  R. Hegele,et al.  Retinopathy and Neuropathy Associated With Complete Apolipoprotein A-l Deficiency , 1996 .

[42]  T. Wong,et al.  Vascular endothelial growth factor and diabetic complications , 2008, Progress in Retinal and Eye Research.

[43]  W. Foulds,et al.  Routes of clearance of radioactive water from the rabbit vitreous. , 1984, The British journal of ophthalmology.

[44]  R. Frank,et al.  Antioxidant enzymes in the macular retinal pigment epithelium of eyes with neovascular age-related macular degeneration. , 1999, American journal of ophthalmology.

[45]  Y. Patel,et al.  Neurotoxic agents reduce retinal somatostatin , 1980, Brain Research.

[46]  N. Sengupta,et al.  Ischemic Vascular Damage Can Be Repaired by Healthy, but Not Diabetic, Endothelial Progenitor Cells , 2007, Diabetes.

[47]  S. Madsen-Bouterse,et al.  Oxidative stress and diabetic retinopathy: Pathophysiological mechanisms and treatment perspectives , 2008, Reviews in Endocrine and Metabolic Disorders.

[48]  H. Nishigori,et al.  Erythropoietin is highly elevated in vitreous fluid of patients with proliferative diabetic retinopathy. , 2005, Diabetes care.

[49]  S. Hamann.  Molecular mechanisms of water transport in the eye. , 2002, International review of cytology.

[50]  P. Mukherjee,et al.  Neuroprotectin D1: a docosahexaenoic acid-derived docosatriene protects human retinal pigment epithelial cells from oxidative stress. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[51]  N. Bazan.  Neurotrophins induce neuroprotective signaling in the retinal pigment epithelial cell by activating the synthesis of the anti-inflammatory and anti-apoptotic neuroprotectin D1. , 2008, Advances in experimental medicine and biology.

[52]  D. Newsome,et al.  Mitochondrial superoxide dismutase in mature and developing human retinal pigment epithelium. , 1992, Investigative ophthalmology & visual science.

[53]  R. H. Steinberg,et al.  Active transport of ions across frog retinal pigment epithelium. , 1977, Experimental eye research.

[54]  A. Nègre-Salvayre,et al.  High-Density Lipoproteins Prevent the Oxidized Low-Density Lipoprotein–Induced Endothelial Growth Factor Receptor Activation and Subsequent Matrix Metalloproteinase-2 Upregulation , 2005 .

[55]  E. Catalani,et al.  Adenylyl Cyclase/cAMP System Involvement in the Antiangiogenic Effect of Somatostatin in the Retina. Results from Transgenic Mice , 2008, Neurochemical Research.

[56]  J. Streilein,et al.  Evidence that retinal pigment epithelium functions as an immune-privileged tissue. , 2000, Investigative ophthalmology & visual science.

[57]  S. Wu,et al.  The retinoid cycle and retina disease , 2003, Vision Research.

[58]  M. O'dorisio,et al.  Somatostatin receptor gene expression in human ocular tissues: RT-PCR and immunohistochemical study. , 2001, Investigative ophthalmology & visual science.

[59]  R. E. Anderson,et al.  Conservation of docosahexaenoic acid in the retina. , 1992, Advances in experimental medicine and biology.

[60]  Wiklund Ra,et al.  First of two parts , 1997 .

[61]  R. Simó,et al.  Somatostatin molecular variants in the vitreous fluid: a comparative study between diabetic patients with proliferative diabetic retinopathy and nondiabetic control subjects. , 2005, Diabetes care.

[62]  N. Ling,et al.  Hypothalamic Polypeptide That Inhibits the Secretion of Immunoreactive Pituitary Growth Hormone , 1973, Science.

[63]  G. Lang,et al.  Octreotide reduces vitreous hemorrhage and loss of visual acuity risk in patients with high-risk proliferative diabetic retinopathy. , 2001, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[64]  Cristina Hernández,et al.  Apolipoprotein A1 is overexpressed in the retina of diabetic patients. , 2009, American journal of ophthalmology.

[65]  L. Rizzolo.  Polarization of the Na+, K(+)-ATPase in epithelia derived from the neuroepithelium. , 1999, International review of cytology.

[66]  R. W. Young,et al.  RENEWAL OF FATTY ACIDS IN THE MEMBRANES OF VISUAL CELL OUTER SEGMENTS , 1974, The Journal of cell biology.

[67]  L. Hjelmeland,et al.  Cellular adhesion regulates bFGF gene expression in human retinal pigment epithelial cells. , 1994, Experimental eye research.

[68]  L. Claesson‐Welsh,et al.  A novel function for tissue inhibitor of metalloproteinases-3 (TIMP3): inhibition of angiogenesis by blockage of VEGF binding to VEGF receptor-2 , 2003, Nature Medicine.

[69]  M. Greenwood,et al.  All five cloned human somatostatin receptors (hSSTR1-5) are functionally coupled to adenylyl cyclase. , 1994, Biochemical and biophysical research communications.

[70]  Kazuki Sato,et al.  Erythropoietin Receptor-mediated Inhibition of Exocytotic Glutamate Release Confers Neuroprotection during Chemical Ischemia* , 2001, The Journal of Biological Chemistry.

[71]  G. King,et al.  Pigment-epithelium-derived factor--a key coordinator of retinal neuronal and vascular functions. , 2000, The New England journal of medicine.

[72]  P. Campochiaro,et al.  Localization of TIMP-3 mRNA expression to the retinal pigment epithelium. , 1996, Investigative ophthalmology & visual science.

[73]  I. Rodriguez,et al.  Intraretinal lipid transport is dependent on high density lipoprotein-like particles and class B scavenger receptors. , 2006, Molecular vision.

[74]  M. Liles,et al.  Antioxidants in the retinal pigment epithelium , 1994, Progress in Retinal and Eye Research.

[75]  D. Rosenbaum,et al.  Involvement of Erythropoietin in Retinal Ischemic Preconditioning , 2009, Anesthesiology.

[76]  C. Sorenson,et al.  PEDF-deficient mice exhibit an enhanced rate of retinal vascular expansion and are more sensitive to hyperoxia-mediated vessel obliteration. , 2008, Experimental eye research.

[77]  C. Heeschen,et al.  Erythropoietin is a potent physiologic stimulus for endothelial progenitor cell mobilization. , 2003, Blood.

[78]  Yi-fei Huang,et al.  [Downregulation of the pigment epithelium derived factor by hypoxia and elevated glucose concentration in cultured human retinal pigment epithelial cells]. , 2003, Zhonghua yi xue za zhi.

[79]  C. Nordgaard,et al.  Human retinal pigment epithelium proteome changes in early diabetes , 2008, Diabetologia.

[80]  W. Gordon,et al.  Docosahexaenoic acid uptake and metabolism in photoreceptors: retinal conservation by an efficient retinal pigment epithelial cell-mediated recycling process. , 1992, Advances in experimental medicine and biology.

[81]  M. Buemi,et al.  NEUROPROTECTIVE EFFECT OF ERYTHROPOIETIN AND DARBEPOETIN ALFA AFTER EXPERIMENTAL INTRACEREBRAL HEMORRHAGE , 2009 .

[82]  A. Barber,et al.  Retinal ganglion cells in diabetes , 2008, Journal of Physiology.

[83]  N. Yoshimura,et al.  Increased production of transforming growth factor-beta 2 from cultured human retinal pigment epithelial cells by photocoagulation. , 1994, Investigative ophthalmology & visual science.

[84]  R. Simó,et al.  Effects of high glucose concentration on the barrier function and the expression of tight junction proteins in human retinal pigment epithelial cells. , 2009, Experimental eye research.

[85]  J. Streilein,et al.  Immunobiology and privilege of neuronal retina and pigment epithelium transplants , 2002, Vision Research.

[86]  M. Boulton,et al.  Erythropoietin: when liability becomes asset in neurovascular repair. , 2008, The Journal of clinical investigation.

[87]  T. Kern,et al.  Oxidative damage in the retinal mitochondria of diabetic mice: possible protection by superoxide dismutase. , 2007, Investigative ophthalmology & visual science.

[88]  M. Slomiany,et al.  Autocrine effects of IGF-I-induced VEGF and IGFBP-3 secretion in retinal pigment epithelial cell line ARPE-19. , 2004, American journal of physiology. Cell physiology.

[89]  M. Tomi,et al.  Inhibition of dehydroascorbic acid transport across the rat blood-retinal and -brain barriers in experimental diabetes. , 2006, Biological & pharmaceutical bulletin.

[90]  K. Kuck,et al.  Erythropoietin and VEGF exhibit equal angiogenic potential. , 2002, Microvascular research.

[91]  Xun Xu,et al.  Erythropoietin protects retinal neurons and glial cells in early-stage streptozotocin-induced diabetic rats. , 2008, Experimental eye research.

[92]  J. B. Lopes de Faria,et al.  Diabetic Retinal Neurodegeneration Is Associated With Mitochondrial Oxidative Stress and Is Improved by an Angiotensin Receptor Blocker in a Model Combining Hypertension and Diabetes , 2009, Diabetes.

[93]  Lois E. H. Smith,et al.  Regulation of vascular endothelial growth factor-dependent retinal neovascularization by insulin-like growth factor-1 receptor , 1999, Nature Medicine.

[94]  R. Simó,et al.  Vitreous levels of IGF-I, IGF binding protein 1, and IGF binding protein 3 in proliferative diabetic retinopathy: a case-control study. , 2000, Diabetes care.

[95]  J. Streilein,et al.  Participation of pigment epithelium in ocular immune privilege. 3. Epithelia cultured from iris, ciliary body, and retina suppress T-cell activation by partially non-overlapping mechanisms , 2003, Ocular immunology and inflammation.

[96]  N. Brecha,et al.  Somatostatin inhibits calcium influx into rat rod bipolar cell axonal terminals , 2001, Visual Neuroscience.

[97]  S. Reichlin.  Somatostatin (First of two parts) , 1983 .

[98]  G. Chader,et al.  FUNCTIONAL PROPERTIES OF INTERPHOTORECEPTOR RETINOID‐BINDING PROTEIN * , 1991, Photochemistry and photobiology.

[99]  V. Sung,et al.  Association of macular involvement with proliferative retinopathy in Type 2 diabetes , 2001, Diabetic medicine : a journal of the British Diabetic Association.

[100]  A. Kvanta.  Expression and secretion of transforming growth factor-beta in transformed and nontransformed retinal pigment epithelial cells. , 1994, Ophthalmic research.

[101]  R. H. Steinberg.  Interactions between the retinal pigment epithelium and the neural retina , 1985, Documenta Ophthalmologica.

[102]  E. Nagelhus,et al.  Aquaporins in complex tissues: distribution of aquaporins 1-5 in human and rat eye. , 1998, American journal of physiology. Cell physiology.

[103]  A. Marmorstein.  The Polarity of the Retinal Pigment Epithelium , 2001, Traffic.

[104]  T. Acott,et al.  Expression of matrix metalloproteinases and inhibitor by human retinal pigment epithelium. , 1990, Investigative ophthalmology & visual science.

[105]  Soo-Hyun Park,et al.  The involvement of phosphatidylinositol 3-kinase /Akt signaling in high glucose-induced downregulation of GLUT-1 expression in ARPE cells. , 2007, Life sciences.

[106]  G. Chader,et al.  Pigment epithelium-derived factor: neurotrophic activity and identification as a member of the serine protease inhibitor gene family. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[107]  P. Hargrave.  Rhodopsin structure, function, and topography the Friedenwald lecture. , 2001, Investigative ophthalmology & visual science.

[108]  J. Sahel,et al.  Hypoglycemia induces general neuronal death, whereas hypoxia and glutamate transport blockade lead to selective retinal ganglion cell death in vitro. , 2001, Investigative ophthalmology & visual science.

[109]  D. Hu,et al.  Erythropoietin protects retinal pigment epithelial cells from oxidative damage. , 2009, Free radical biology & medicine.

[110]  R. Simó,et al.  Fenofibrate for diabetic retinopathy , 2007, The Lancet.

[111]  M. Kasuga,et al.  Low phagocytic activity of resident peritoneal macrophages in diabetic mice: relevance to the formation of advanced glycation end products. , 1999, Diabetes.

[112]  Aniq B. Darr,et al.  Glucose utilization by the retinal pigment epithelium: evidence for rapid uptake and storage in glycogen, followed by glycogen utilization. , 2006, Experimental eye research.

[113]  J. Edelman,et al.  Active ion transport pathways in the bovine retinal pigment epithelium. , 1990, The Journal of physiology.

[114]  G. Vrensen,et al.  Vascular endothelial growth factors and angiogenesis in eye disease , 2003, Progress in Retinal and Eye Research.

[115]  R. Simó,et al.  Proteomic analysis of human vitreous fluid by fluorescence-based difference gel electrophoresis (DIGE): a new strategy for identifying potential candidates in the pathogenesis of proliferative diabetic retinopathy , 2007, Diabetologia.

[116]  T. Kitaoka,et al.  Distribution of FGF-5 in the rhesus macaque retina. , 1994, Investigative ophthalmology & visual science.

[117]  Y. Koutalos,et al.  Interphotoreceptor retinoid-binding protein is the physiologically relevant carrier that removes retinol from rod photoreceptor outer segments. , 2007, Biochemistry.

[118]  L. Rizzolo,et al.  Regulation of glucose transporters during development of the retinal pigment epithelium. , 2000, Brain research. Developmental brain research.

[119]  Cathy Frey,et al.  Investigative Ophthalmology and Visual Science , 2010 .

[120]  D Carden,et al.  Macular pigment and risk for age-related macular degeneration in subjects from a Northern European population. , 2001, Investigative ophthalmology & visual science.

[121]  J. Tombran-Tink,et al.  Pigment epithelium‐derived factor protects cultured retinal neurons against hydrogen peroxide‐induced cell death , 1999, Journal of neuroscience research.

[122]  C. Contreras-Cubas,et al.  Ascorbate uptake in normal and diabetic rat retina and retinal pigment epithelium. , 2007, Comparative biochemistry and physiology. Toxicology & pharmacology : CBP.

[123]  J. Tombran-Tink,et al.  In vivo protection of photoreceptors from light damage by pigment epithelium-derived factor. , 2001, Investigative ophthalmology & visual science.

[124]  R. Simó,et al.  Angiogenic and antiangiogenic factors in proliferative diabetic retinopathy. , 2006, Current diabetes reviews.

[125]  N. Congdon,et al.  Important causes of visual impairment in the world today. , 2003, JAMA.

[126]  P. Ghezzi,et al.  Erythropoietin exerts an anti-inflammatory effect on the CNS in a model of experimental autoimmune encephalomyelitis , 2002, Brain Research.

[127]  S. Vilaró,et al.  Erythropoietin protects the in vitro blood–brain barrier against VEGF‐induced permeability , 2003, The European journal of neuroscience.

[128]  F. Lamoke,et al.  Neuroprotective role of erythropoietin by antiapoptosis in the retina , 2009, Journal of neuroscience research.

[129]  F. Gonzalez-fernandez,et al.  Internalization of interphotoreceptor retinoid‐binding protein by the Xenopus retinal pigment epithelium , 2003, The Journal of comparative neurology.

[130]  谷原 秀信.  Identification of transforming growth factor-β expressed in cultured human retinal pigment epithelial cells , 1993 .

[131]  C. Curcio,et al.  Apolipoprotein localization in isolated drusen and retinal apolipoprotein gene expression. , 2006, Investigative ophthalmology & visual science.

[132]  C. Curcio,et al.  Accumulation of cholesterol with age in human Bruch's membrane. , 2001, Investigative ophthalmology & visual science.

[133]  G. Palade,et al.  Increased microvascular permeability and endothelial fenestration induced by vascular endothelial growth factor. , 1995, Journal of cell science.

[134]  S. H. Wilson,et al.  The therapeutic problem of proliferative diabetic retinopathy: targeting somatostatin receptors. , 2001, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[135]  P. Campochiaro,et al.  Platelet-derived growth factor is an autocrine growth stimulator in retinal pigmented epithelial cells. , 1994, Journal of cell science.

[136]  M. Liles,et al.  Human retinal pigment epithelium contains two distinct species of superoxide dismutase. , 1990, Investigative ophthalmology & visual science.

[137]  V. Gaur,et al.  Cellular localization of somatostatin mRNA in rat retina , 1990, Neuropeptides.

[138]  S. Finnemann.  Focal adhesion kinase signaling promotes phagocytosis of integrin‐bound photoreceptors , 2003, The EMBO journal.

[139]  S. Binder,et al.  Correlation of different circulating endothelial progenitor cells to stages of diabetic retinopathy: first in vivo data. , 2009, Investigative ophthalmology & visual science.

[140]  J. Crider,et al.  The effects of elevated glucose on Na+/K(+)-ATPase of cultured bovine retinal pigment epithelial cells measured by a new nonradioactive rubidium uptake assay. , 1997, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

[141]  Lois E. H. Smith,et al.  Erythropoietin deficiency decreases vascular stability in mice. , 2008, The Journal of clinical investigation.

[142]  S. Hokari,et al.  Apolipoprotein A-I concentration in tears in diabetic retinopathy , 2002, Annals of clinical biochemistry.

[143]  D. Hinton,et al.  Transdifferentiated retinal pigment epithelial cells are immunoreactive for vascular endothelial growth factor in surgically excised age-related macular degeneration-related choroidal neovascular membranes. , 1996, Investigative ophthalmology & visual science.

[144]  S. P. Becerra,et al.  Erythropoietin--an endogenous retinal survival factor. , 2002, The New England journal of medicine.

[145]  A Kijlstra,et al.  Polarized vascular endothelial growth factor secretion by human retinal pigment epithelium and localization of vascular endothelial growth factor receptors on the inner choriocapillaris. Evidence for a trophic paracrine relation. , 1999, The American journal of pathology.

[146]  D. Rosenbaum,et al.  Erythropoietin administration protects retinal neurons from acute ischemia-reperfusion injury , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[147]  R. Bucala,et al.  Advanced glycation end products increase retinal vascular endothelial growth factor expression. , 1998, The Journal of clinical investigation.

[148]  C. Grimm,et al.  HIF-1-induced erythropoietin in the hypoxic retina protects against light-induced retinal degeneration , 2002, Nature Medicine.

[149]  L. Hjelmeland,et al.  Coexpression of FGF-5 and bFGF by the retinal pigment epithelium in vitro. , 1992, Experimental eye research.

[150]  D. Yee,et al.  Gene expression of the insulin-like growth factors and their receptors in cultured human retinal pigment epithelial cells. , 1992, Brain Research. Molecular Brain Research.

[151]  O. Strauß,et al.  Antiapoptotic properties of erythropoietin: novel strategies for protection of retinal pigment epithelial cells , 2009, Eye.

[152]  Juliette Johnson,et al.  Somatostatin and somatostatin subtype 2A expression in the mammalian retina , 2000, Microscopy research and technique.

[153]  H. H. Marti,et al.  Erythropoietin and the hypoxic brain , 2004, Journal of Experimental Biology.

[154]  P. Durrington,et al.  HDL, its enzymes and its potential to influence lipid peroxidation. , 1995, Atherosclerosis.

[155]  Kanji A. Takahashi,et al.  Pigment epithelium derived factor as a neuroprotective agent against ischemic retinal injury , 2001, Current eye research.

[156]  A. Iannaccone,et al.  Pigment Epithelium-Derived Factor Supports Normal Development of Photoreceptor Neurons and Opsin Expression after Retinal Pigment Epithelium Removal , 2000, The Journal of Neuroscience.

[157]  R. Simó,et al.  Strategies for blocking angiogenesis in diabetic retinopathy: from basic science to clinical practice , 2007, Expert opinion on investigational drugs.

[158]  M. Gassmann,et al.  Brain‐derived erythropoietin protects from focal cerebral ischemia by dual activation of ERK‐1/‐2 and Akt pathways , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[159]  D. Bok,et al.  The retinal pigment epithelium: a versatile partner in vision , 1993, Journal of Cell Science.

[160]  David,et al.  Phagocytosis and H2O2 induce catalase and metallothionein gene expression in human retinal pigment epithelial cells. , 1995, Investigative ophthalmology & visual science.

[161]  L. Rizzolo.  The distribution of Na+,K(+)-ATPase in the retinal pigmented epithelium from chicken embryo is polarized in vivo but not in primary cell culture. , 1990, Experimental eye research.

[162]  T. Sano,et al.  [Diabetic retinopathy]. , 2001, Nihon rinsho. Japanese journal of clinical medicine.

[163]  T. Shinohara,et al.  Lens epithelium-derived growth factor (LEDGF) delays photoreceptor degeneration in explants of rd/rd mouse retina , 2001, Neuroreport.

[164]  D. Antonetti,et al.  Vascular permeability in ocular disease and the role of tight junctions , 2007, Angiogenesis.

[165]  P. Bagnoli,et al.  Antiangiogenic role of somatostatin receptor 2 in a model of hypoxia-induced neovascularization in the retina: results from transgenic mice. , 2007, Investigative ophthalmology & visual science.

[166]  P. Witkovsky,et al.  Somatostatin Modulates Voltage-Gated K+ and Ca2+ Currents in Rod and Cone Photoreceptors of the Salamander Retina , 2000, The Journal of Neuroscience.

[167]  Gary R. Grotendorst,et al.  Retinal pigment epithelial cells produce PDGF-like proteins and secrete them into their media. , 1989, Experimental eye research.

[168]  M. Liles,et al.  Evaluation of oxidative processes in human pigment epithelial cells associated with retinal outer segment phagocytosis. , 1994, Experimental cell research.

[169]  G. Lang,et al.  Octreotide prevents growth factor-induced proliferation of bovine retinal endothelial cells under hypoxia. , 2004, The Journal of endocrinology.

[170]  L. Helboe,et al.  Immunohistochemical localization of somatostatin receptor subtypes sst1 and sst2 in the rat retina. , 1999, Investigative ophthalmology & visual science.

[171]  E. Friedman,et al.  Treating azotemia-induced anemia with erythropoietin improves diabetic eye disease. , 2003, Kidney international. Supplement.

[172]  G. Chader,et al.  Interphotoreceptor retinoid-binding protein (IRBP). Molecular biology and physiological role in the visual cycle of rhodopsin. , 1993, Molecular neurobiology.

[173]  B. Vialettes,et al.  Stabilization of severe proliferative diabetic retinopathy by long-term treatment with SMS 201-995. , 1992, Diabete & metabolisme.

[174]  K. Valter,et al.  Cellular and subcellular patterns of expression of bFGF and CNTF in the normal and light stressed adult rat retina. , 2001, Experimental eye research.

[175]  M. Tomi,et al.  Advances in the cell biology of transport via the inner blood-retinal barrier: establishment of cell lines and transport functions. , 2005, Biological & pharmaceutical bulletin.

[176]  G. Chader,et al.  Interphotoreceptor retinoid-binding protein promotes rhodopsin regeneration in toad photoreceptors. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[177]  E. Nagelhus,et al.  Cellular and subcellular expression of monocarboxylate transporters in the pigment epithelium and retina of the rat , 1999, Neuroscience.

[178]  A. Girotti,et al.  Role of lipid hydroperoxides in photo-oxidative stress signaling. , 2004, Antioxidants & redox signaling.

[179]  I. Rodriguez,et al.  Uptake of cholesterol by the retina occurs primarily via a low density lipoprotein receptor-mediated process. , 2006, Molecular vision.

[180]  J. Epelbaum,et al.  NADPH-diaphorase colocalization with somatostatin receptor subtypes sst2A and sst2B in the retina. , 2001, Investigative ophthalmology & visual science.

[181]  J. Weiter,et al.  Precocious retinal adhesion is affected by furosemide and ouabain. , 1989, Current eye research.

[182]  D. Bok,et al.  TIMP-3 is expressed in the human retinal pigment epithelium. , 1996, Biochemical and biophysical research communications.

[183]  J. Stewart,et al.  Pathophysiology of Diabetic Macular Edema , 2009, International ophthalmology clinics.

[184]  R. Simó,et al.  Deficit of somatostatin-like immunoreactivity in the vitreous fluid of diabetic patients: possible role in the development of proliferative diabetic retinopathy. , 2002, Diabetes care.

[185]  D. Hicks,et al.  Renewal of photoreceptor outer segments and their phagocytosis by the retinal pigment epithelium. , 2000, International review of cytology.

[186]  M. Lavail,et al.  Mechanical injury increases bFGF and CNTF mRNA expression in the mouse retina. , 1997, Experimental eye research.

[187]  W. Benedict,et al.  Pigment epithelium-derived factor: a potent inhibitor of angiogenesis. , 1999, Science.

[188]  M. Boulton,et al.  Macular pigment and age related macular degeneration , 1999, The British journal of ophthalmology.

[189]  R. Simó,et al.  Expression of Erythropoietin and Its Receptor in the Human Retina , 2008, Diabetes Care.

[190]  W. Hauswirth,et al.  Gene therapy restores vision-dependent behavior as well as retinal structure and function in a mouse model of RPE65 Leber congenital amaurosis. , 2006, Molecular therapy : the journal of the American Society of Gene Therapy.

[191]  S. Masuda,et al.  Erythropoietin as a retinal angiogenic factor in proliferative diabetic retinopathy. , 2005, The New England journal of medicine.

[192]  R. Simó,et al.  Vitreous levels of vascular cell adhesion molecule and vascular endothelial growth factor in patients with proliferative diabetic retinopathy: a case-control study. , 2001, Diabetes care.

[193]  P. Wiedemann,et al.  Modulation of matrix metalloproteinase and TIMP-1 expression by cytokines in human RPE cells. , 2002, Investigative ophthalmology & visual science.

[194]  D. Frambach,et al.  Chloride transport in cultured fetal human retinal pigment epithelium. , 1996, Experimental eye research.

[195]  W. Jelkmann,et al.  Effects of erythropoietin on brain function. , 2005, Current pharmaceutical biotechnology.

[196]  Olaf Strauss,et al.  The retinal pigment epithelium in visual function. , 2005, Physiological reviews.

[197]  Y Horio,et al.  Immunogold evidence suggests that coupling of K+ siphoning and water transport in rat retinal Müller cells is mediated by a coenrichment of Kir4.1 and AQP4 in specific membrane domains , 1999, Glia.

[198]  F. Gonzalez-fernandez,et al.  Focus on Molecules: interphotoreceptor retinoid-binding protein (IRBP). , 2008, Experimental eye research.

[199]  M. Burns,et al.  The retinal pigment epithelium induces fenestration of endothelial cells in vivo. , 1992, Current eye research.